Abstract Number: 1548 • 2015 ACR/ARHP Annual Meeting
Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort
Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in RA. Management and stratification of ASCVD in RA patients is still a matter…Abstract Number: 2677 • 2015 ACR/ARHP Annual Meeting
Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in Patients with Rheumatoid Arthritis
Background/Purpose: Numerous studies have reported increased cardiovascular morbidity and mortality in rheumatoid arthritis (RA) patients that cannot be explained by traditional risk factors. In a…Abstract Number: 1542 • 2015 ACR/ARHP Annual Meeting
Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis
Background/Purpose: Arterial vascular events have a great impact in the morbidity and mortality of rheumatoid arthritis (RA). Traditional and nontraditional risk factors for arterial vascular…Abstract Number: 2636 • 2015 ACR/ARHP Annual Meeting
Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-Based Cohort
Title: Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-based Cohort Background/Purpose: Patients with rheumatoid arthritis (RA) have increased risk of cardiovascular…Abstract Number: 1540 • 2015 ACR/ARHP Annual Meeting
Cardiovascular Risk Management in Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) patients have been previously shown to have a higher cardiovascular (CV) burden as compared to the general population. The CV risk…Abstract Number: 2630 • 2015 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up
Background/Purpose: The main cause of mortality in patients with rheumatoid arthritis (RA) is atherosclerotic cardiovascular disease (ASCVD). RA patients have a 10-year decrease in life…Abstract Number: 1501 • 2015 ACR/ARHP Annual Meeting
Prevalence of Unassessed and Uncontrolled Cardiovascular Disease Risk Factors Among Rheumatoid Arthritis Patients in an Academic Rheumatology Practice
Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death in individuals with rheumatoid arthritis (RA). Patients with RA are at 1.5-2.0-fold increased risk of…Abstract Number: 2131 • 2015 ACR/ARHP Annual Meeting
Younger Age and Female Gender Are the Main Determinants of Underestimation of Cardiovascular Risk in Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) patients have an increased cardiovascular (CV) risk. Current algorithms generally underestimate the risk in these patients [1]. In a meta-analysis, we…Abstract Number: 1298 • 2015 ACR/ARHP Annual Meeting
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH): A Collaborative and Systems-Based Approach to Improve Access to Care
Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) as compared to the general population. The European League Against Rheumatism…Abstract Number: 2130 • 2015 ACR/ARHP Annual Meeting
Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Low-Dose Aspirin: A Case-Crossover Study
Background/Purpose: Subjects with rheumatoid arthritis (RA) are at a higher risk of developing cardiovascular (CV) disease which is the leading cause of death in subjects…Abstract Number: 1673 • 2015 ACR/ARHP Annual Meeting
The Transcription Factor Nuclear Protein Transcriptional Regulator 1 May Contribute to Increased Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis
Background/Purpose: The cause of accelerated atherosclerosis in rheumatoid arthritis (RA) is still unclear and appears to be multifactorial. Besides the traditional risk factors, also RA-specific…Abstract Number: 1615 • 2015 ACR/ARHP Annual Meeting
Lack of Replication of the Association Between Anti-Citrullinated Fibrinogen and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
Background/Purpose: A recent study has suggested that the excess cardiovascular (CV) risk observed in patients with rheumatoid arthritis (RA) could be partially explained by immune-complexes…Abstract Number: 1611 • 2015 ACR/ARHP Annual Meeting
Gene Expression Profiling Reflects Increased Expression of Coronary Artery Disease Associated Genes in a Case-Control Matched Study of Patient with Rheumatoid Arthritis
Background/Purpose: Peripheral blood gene expression profiling has been used to identify gene signatures which reflect a variety of pathologic conditions. The CorusCAD¨ test is a…Abstract Number: 1595 • 2015 ACR/ARHP Annual Meeting
Impaired Coronary Flow Reserve in Rheumatoid Arthritis: A Robust Indicator of Cardiac Structure Associated with Systemic Inflammation and Rheumatoid Arthritis Treatments
Background/Purpose: Myocardial microvascular dysfunction may precede or coexist with coronary atherosclerosis and heart failure, two conditions over-represented in RA. Coronary flow reserve (CFR) offers an…Abstract Number: 1593 • 2015 ACR/ARHP Annual Meeting
Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis
Background/Purpose: Telomeres protect against DNA damage and shorten with each cell division; their length may be a marker of cardiovascular and overall biological aging. Patients…
ACR Meeting Abstracts